Contract W81K0217P0434
Abbott Laboratories Inc. · Department Of Defense · September 16, 2021
Abbott Laboratories Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on September 16, 2021 for $6.91 million (current value) of work in in-vitro diagnostic substance manufacturing. Performance is in North Chicago, IL. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $6.91 million.
Contract details
- PIID
- W81K0217P0434
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- North Chicago, IL
- First action
- September 16, 2021
Description
CLINICAL CHEMISTRY REAGENTS, IA IMMUNOASSAYS REAGENTS AND ANALYZERS- ADD MANDATORY DHA RMF AND MHS GENESIS LANGUAGE
Modification timeline
-
September 16, 2021Mod P00013 · Supplemental Agreement For Work Within Scope$6.91M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0217P0434?
Contract W81K0217P0434 is a federal contract awarded to Abbott Laboratories Inc. by Department Of Defense on September 16, 2021 for $6.91 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract W81K0217P0434?
Abbott Laboratories Inc. won contract W81K0217P0434 from Department Of Defense.
How much is contract W81K0217P0434 worth?
Contract W81K0217P0434 has obligated $0 to date but carries a potential ceiling of $6.91 million if fully funded and all options are exercised.